|
|
1982 Innerbelt Business Center Dr.
St. Louis
MO
63114
United States
314-429-7367
|
|
Private
|
Envisioneering Medical Products is an innovative medical technology company that develops, manufactures and markets proprietary diagnostic and treatment solutions for the healthcare marketplace. Based in St. Louis, Envisioneering was founded to continue development and commercialization of a unique and proprietary scanning technology that allows ultrasound to replicate the functionality of MRI while the scanner/probe remains stationary, and also enables a new generation of planned and targeted biopsies and treatments. The Company's initial product offering, the TargetScan® System for prostate imaging and biopsy, combines proprietary 3D ultrasound technology with the capability to perform precise, targeted prostate biopsies and treatments in order to add confidence to patient diagnosis. With Envisioneering's proprietary technology, cost effective, true 3D with real-world clinical applications will become the standard of care in most ultrasound imaging modalities.
|
|
http://www.envisioneeringmedical.com
|
|
|
|
|
|
|
|
|
|
TargetScan System - Targeted Biopsy System Product Literature
The Targeted Biopsy System offers numerous advantages
With the Targeted Biopsy System, you have the ability to more confidently target areas of the prostate to plan the preferred locations of tissue samples in the different quadrants of the prostate, and save this biopsy plan to file.
The Targeted Biopsy System then allows the physician to insert a biopsy needle in the targeted area, monitor the accuracy of the needle position and the specific location of the tissue sample. Images can be then
read more...
|
|
TRUS - Transrectal Ultrasound Product Literature
Transrectal ultrasound (TRUS), also called prostate ultrasound, provides images of the prostate and surrounding tissue and allows the physician to examine the gland for abnormalities (e.g., enlarged prostate (BPH), prostate cancer). TRUS and prostate biopsy can be used to diagnose prostate cancer in patients with an abnormal digital rectal examination or elevated PSA level, to assess prostate volume, to detect inflammation of the prostate (e.g., prostatitis), and to help determine the cause of i
read more...
|
|
|
|
|
|
|